Sale is live|00:00:00
DCW LtdQ1 FY23

DCW Ltd

Q1 FY23 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • CPVC and SIOP segments expected to grow with strong demand; CPVC demand is growing in double digits, especially in lower-tier cities and rural India.
  • SIOP capacity utilization increased to ~80% with consistent growth in revenues and margins; plans to expand footprint in European markets.
  • Specialty chemicals to maintain margins north of 35% with increasing volumes starting Quarter 2 and Quarter 3.
  • Commodity chemicals like caustic soda prices seen as bottomed out; expected recovery as China's domestic demand improves.
  • Overall volumes expected to increase with capacity additions in CPVC and SIOP, providing annualized EBITDA north of ₹220 crores post capex.
  • Margins across segments expected to be maintained, with some quarter-to-quarter fluctuations due to price moves.
  • Company targets a balanced portfolio between specialty and commodity chemicals for sustainable margin protection.

Margin guidance

Category 3
  • Annualized profit from CPVC and SIOP capacity expected to be north of ₹200 crores post capacity coming online; current year will see partial benefit (Page 16).
  • Specialty chemicals (SIOP and CPVC) projected EBITDA: ₹115 crores this year and over ₹220 crores next year post capex (Page 14).
  • EBITDA margin for CPVC and SIOP expected to remain north of 35% on increased volumes (Page 6).
  • Total EBITDA expected to exceed ₹200 crores with contributions from PVC (5-7% margin), caustic (3-4% margin), and soda ash segments (Page 15).
  • EPS expected to grow with increased volumes and profitability in specialty chemicals and stabilization/recovery in commodity chemicals (implied across pages).
  • Interest cost reduction and strong free cash flow to support profitability; no immediate debt repayment planned, allowing internal accruals to fund growth (Page 14 & 9).
  • Long-term growth guided by capacity expansions, specialty chemical focus, and trading volumes (Pages 13, 11).

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for DCW Ltd and 1,400+ other companies.

Fundraise plans

  • No immediate plans to repay debt; the company prefers to let debt reduce naturally through scheduled repayments (125 crores this year).
  • Current gross debt stands at approximately 504 crores, with cash balances around 160 crores, resulting in net debt of about 340 crores.
  • Management indicates the cost of borrowing has significantly reduced to sub-10% from around 17%.
  • There is no explicit mention of new fundraising through debt or equity in the current period.
  • Future decisions on debt repayment or new funding will depend on upcoming CAPEX requirements and growth projects, especially after completion of ongoing projects.
  • The company is considering internal accruals to fund future CAPEX.
  • No clear indication of equity fundraising or fresh debt issuance at present; the focus is on managing existing financial resources efficiently.

Order book

- The transcript does not explicitly mention the current or expected order book or pending orders. - However, there is an indication of growth and positive demand in segments like CPVC and SIOP, with capacity expansions underway and expected volume ramp-up starting Q3 FY24. - The company anticipates maintaining strong margins above 35% for specialty chemicals (SIOP and CPVC) with increased volumes. - Discussions show confidence in sustaining or improving EBITDA supported by additional volumes despite price corrections. - Management indicated stable operations with no mention of any backlog or pending orders causing concern. - The company is focused on completing announced projects quickly to support the next phase of growth, implying active order flow and production ramp-up aligned with capacity expansions. No direct order book numbers are provided in the transcript on page 17 or surrounding pages.

Capex plans

Yes
  • Current announced CAPEX is around ₹125 crores for doubling CPVC capacity and debottlenecking SIOP, with about ₹60 crores spent as of March 31 and 70% work done; some cost savings anticipated.
  • Additional balance CAPEX of around ₹60 crores is required to complete announced projects.
  • Routine CAPEX is about ₹30-40 crores.
  • Total expected CAPEX spend including routine and announced projects for the year is around ₹100 crores.
  • Future CAPEX includes making the Sahupuram facility chlorine neutral as part of ESG initiatives.
  • Management is exploring renewable energy options like solar to reduce energy costs and carbon footprint.
  • After completing current projects, the company plans to evaluate the next growth driver for FY25, including possible geographic de-risking and further expansion.
  • Debt repayment decisions (₹125 crores repayment planned this year) will depend on CAPEX requirements and internal accruals.

How does DCW Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1DCW Ltd
Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Unlock with Pro

Want more stocks like DCW Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio